VintaBio
1 known investors
VintaBio provides viral vector manufacturing for clinical and commercial gene therapies, using a single-stream process (VintaProcess) to produce high-yield, high-purity vectors. It offers end-to-end services from discovery through final delivery for cell and gene therapy developers.
Investors · 1
In the news
Frequently asked questions
- What does VintaBio do?
- VintaBio provides viral vector manufacturing for clinical and commercial gene therapies, using a single-stream process (VintaProcess) to produce high-yield, high-purity vectors. It offers end-to-end services from discovery through final delivery for cell and gene therapy developers.
- Who are VintaBio's investors?
- VintaBio's investors include Decheng Capital.